Quanta Biosciences and IDT partner to develop and produce microRNA PCR

23-Mar-2011 - USA

Quanta Biosciences has developed hundreds of assays for quantifying microRNAs, and has entered into a partnership with Integrated DNA Technologies to custom manufacture them.

MicroRNAs have been shown to play a key role in cancer as well as many biological processes including neurological and cardiac function. Quanta’s portfolio of microRNA products will allow scientists to accurately detect and profile mature miRNA (miR) sequences.  Early access customers have deployed Quanta’s microRNA assays for  toxicology screening during drug development, and quality control of stem-cell pluripotency and differentiation.  IDT will produce the assays and supply them through an online catalog directly to Quanta’s customers.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances